Clinical Overview
Apremilast is an oral small-molecule phosphodiesterase 4 (PDE4) inhibitor on the WHO Model List of Essential Medicines. By inhibiting PDE4, it elevates intracellular cyclic adenosine monophosphate (cAMP), down-regulating pro-inflammatory cytokine expression (TNF-alpha, IL-17, IL-23) while up-regulating anti-inflammatory IL-10. Indicated for moderate-to-severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy, and active psoriatic arthritis.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally with water, with or without meals, twice daily following the initial 5-day dose-titration schedule (10 mg to 30 mg). Swallow tablets whole; do not crush or chew. Titration minimizes gastrointestinal adverse effects.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Diarrhea (usually within first 2 weeks, transient), nausea, upper respiratory tract infection, tension headache, weight loss. Rare/Severe: Severe depression and suicidal ideation, severe prolonged diarrhea, and hypersensitivity.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Monitor for new or worsening depression and suicidal thoughts. Monitor body weight regularly; evaluate unexplained significant weight loss. Reduce dose to 30 mg once daily in severe renal impairment (CrCl < 30 mL/min).
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered dermatologist or qualified medical practitioner before initiating, altering, or substituting any topical or systemic dermatological treatment.